Robeco Institutional Asset Management B.V. Atri Cure, Inc. Transaction History

Robeco Institutional Asset Management B.V.

$49.7 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $15,076 - $19,765	457 New	457 $16,000
Q4 2023 Feb 08, 2024	BUY	$32.99 - $43.25 $0 - $0	0 New	0 $457,000
Q1 2019 May 02, 2019	SELL	$26.38 - $33.34 $164,136 - $207,441	-6,222 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$26.66 - $34.85 $165,878 - $216,836	6,222 New	6,222 $190,000

Others Institutions Holding ATRC

# of Institutions

206

Shares Held

49.3M

Call Options Held

111K

Put Options Held

23.8K

Vanguard Group Inc Valley Forge, PA

4.62M
Shares

$161 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.62M
Shares

$161 Million
0.0% of portfolio
Alliancebernstein L.P. New York, NY

4.2M
Shares

$146 Million
0.03% of portfolio
Champlain Investment Partners, LLC Burlington, VT

2.67M
Shares

$93.2 Million
0.39% of portfolio
Macquarie Group LTD Australia, C3

2M
Shares

$69.6 Million
0.05% of portfolio

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.62B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account